Concepedia

Publication | Open Access

95MO Tinengotinib in patients with advanced, fibroblast growth factor receptor (FGFR) inhibitor refractory/relapsed cholangiocarcinoma

11

Citations

0

References

2023

Year

No additional data available for this publication yet. Check back later!